(Q35743997)

English

G2 checkpoint abrogators as anticancer drugs

scientific article published on April 2004

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

Europe PubMed Central

title

G2 checkpoint abrogators as anticancer drugs (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10 August 2017

Takumi Kawabe

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15078995

retrieved

10 August 2017

publication date

1 April 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15078995

retrieved

10 August 2017

published in

Molecular Cancer Therapeutics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15078995

retrieved

10 August 2017

volume

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15078995

retrieved

10 August 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15078995

retrieved

10 August 2017

page(s)

513-519

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15078995

retrieved

10 August 2017

Identifiers

PubMed publication ID

15078995

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15078995

retrieved

10 August 2017

(Q35743997)

G2 checkpoint abrogators as anticancer drugs

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)